DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

International Gemological Institute Limited — Board Meeting Intimation

NSE 46 min ago·12 Oct 2026, 7:07 am

International Gemological Institute

International Gemological Institute Limited (IGIL) has announced that its board will meet on October 21, 2026, to review and approve the company's unaudited financial results for the quarter ended September 2026. This is a routine corporate governance procedure that allows the board to formally assess the firm's performance before the figures are made public.

For investors, this announcement is a key milestone as it will provide the first glimpse into the company's financial health during the third quarter of the fiscal year. The results will likely highlight changes in revenue, expenses, and profitability, which are critical indicators for assessing the company's current operational momentum.

Investors should watch for the release of these results to gauge the company's performance against market expectations. Any significant deviation from forecasts or commentary from management regarding future outlook could provide valuable insights into the stock's short-term trajectory.